Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the complete record of transactions filed by Wang Philip Li, Directivo. Insider active across 2 companies, notably Shanghai Bio-heart Biological Technology Co., Ltd. - B. In total, 66 disclosures have been published. History available since 17 April 2026. The latest transaction was filed on 24 July 2026 (Purchase). Regulator: HKEX. All data is free.
Companies and markets linked to Wang Philip Li
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10.000 títulos@ 2,56 HKD0.3% de su flujoShareXHKGHKEX:DA20260617E00070
25 de 66 declaraciones
About Wang Philip Li
Wang Philip Li is a Dirigeant and a director of Shanghai Bio-heart Biological Technology Co., Ltd. - B -H Sh and Shanghai Bio-heart Biological Technology Co., Ltd. - B, on XHKG. Across 58 filings in total, the 58 sampled filings run from 2026-04-17 to 2026-07-14 and are all purchases, with a total amount of EUR 1224983.